4.4 Article

Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

Journal

HEART FAILURE REVIEWS
Volume 15, Issue 1, Pages 103-107

Publisher

SPRINGER
DOI: 10.1007/s10741-009-9156-8

Keywords

Duchenne; Dystrophin; Heart failure; ACE inhibitors; Beta-blockers; Experimental therapies

Ask authors/readers for more resources

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the absence of dystrophin, a sarcolemmal protein which links the cytoskeleton to the extracellular matrix by interacting with a large number of proteins. Heart failure is a classic complication of this disease. The authors review the pathogenesis and therapeutics of cardiac involvement in DMD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available